ImmunityBio has gained the FDA authorisation for an EAP to supply an alternative source of BCG for treating bladder cancer.

Shares of ImmunityBio Inc. surged 16.4% on Wednesday, marking their best session in over a month, and extended gains in after ...

It is pertinent to note that many men are unaware of the existence of the prostate gland let alone it's diseases, symptoms thereof and implications. The prostate is a small walnut shaped gland ...

Despite the physical and mental battles, and constant medical appointments, Sandor, 44, and Erika, 54, say they are "determined to keep living, creating and find peace in nature".

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to ...

Shilpa Gupta, MD, discusses the key takeaways from the long-term outcomes of the JAVELIN Bladder 100 trial for community ...

Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe in patients with ...

Studies from Munich University highlighted quality of life in bladder and prostate cancer at ASCO 2025 Genitourinary Cancers ...

A new analysis out of Sweden reports that disinfecting water with chlorine creates chemical byproducts that can increase the risk of bladder cancer by 33% and colorectal cancer by 15%.

ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an "alternative source ...

Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the ...